alexa

GET THE APP

Progressive Fulminant Demyelinating Neuropathy Associated with Paranodal Antibodies | OMICS International| Abstract

The Neurologist: Clinical & Therapeutics Journal
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Case Report   
  • Neurol Clin Therapeut J 2018, Vol 2(1): 1

Progressive Fulminant Demyelinating Neuropathy Associated with Paranodal Antibodies

Tiwana HK*, Bandyopadhyay S, Kaur D, Specht CS and Ahmed A
Department of Neurology, Penn State Hershey Medical Center, , Hershey, Pennsylvania, USA
*Corresponding Author : Tiwana HK, Department of Neurology, Penn State Hershey Medical Center, Hershey, Pennsylvania, USA, Tel: +1 888-567-9440, Email: [email protected]

Received Date: Mar 30, 2018 / Accepted Date: Apr 24, 2018 / Published Date: May 01, 2018

Abstract

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a clinical condition with complex immune based pathology. There are different types of immune mediated markers associated with CIDP that describe different subtypes of the disease but data on paranodal antibodies associated with striational and potassium channel antibodies is lacking.

Keywords: Chronic inflammatory demyelinating polyneuropathy; Paranodal antibodies; Immunoglobulin; Hematoxylin

Citation: Tiwana HK, Bandyopadhyay S, Kaur D, Specht CS, Ahmed A (2018) Progressive Fulminant Demyelinating Neuropathy Associated with Paranodal Antibodies. Neurol Clin Therapeut J 2: 104.

Copyright: © 2018 Tiwana HK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Article Usage
  • Total views: 1941
  • [From(publication date): 0-2018 - Jan 21, 2022]
  • Breakdown by view type
  • HTML page views: 1570
  • PDF downloads: 371
Top